FN1 and cancer: Decreasing fibronectin in cancer irrespective of how this is achieved, by deletion of fibronectin in cancer cells, by decreasing circulating and hence infiltrating fibronectin or by preventing its accumulation by treatment with pUR4 diminishes cancer growth.